Dr. Sehouli on Considering Secondary Cytoreductive Surgery in Ovarian Cancer

Jalid Sehouli, MD
Published: Friday, Nov 10, 2017



Jalid Sehouli, MD, professor, director of the Clinic Campus Virchow and Campus Benjamin Franklin Charité Center Gynecology, Charité – Universitatsmedizin Berlin, advises physicians on considering secondary cytoreductive surgery in ovarian cancer.

Sehouli’s advice for physicians that are considering secondary cytoreductive surgery for their patients is to take in account previous treatment, tumor pattern, and symptoms. From there, they must define a treatment goal and consider the infrastructure of their institution.
 


Jalid Sehouli, MD, professor, director of the Clinic Campus Virchow and Campus Benjamin Franklin Charité Center Gynecology, Charité – Universitatsmedizin Berlin, advises physicians on considering secondary cytoreductive surgery in ovarian cancer.

Sehouli’s advice for physicians that are considering secondary cytoreductive surgery for their patients is to take in account previous treatment, tumor pattern, and symptoms. From there, they must define a treatment goal and consider the infrastructure of their institution.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Redefining Ovarian Cancer Treatment Paradigms by Maximizing Therapeutic Outcomes with PARP InhibitorsSep 29, 20182.0
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Publication Bottom Border
Border Publication
x